Unknown

Dataset Information

0

Transcriptomic dataset of Mycolicibacterium smegmatis exposed to an imidazo[1,2-b][1,2,4,5]tetrazine.


ABSTRACT: Deciphering the mechanism of action of novel anti-tuberculosis compounds is a key step in the drug development process. We have previously described a number of imidazo[1,2-b][1,2,4,5]tetrazines with a promising activity on Mycobacterium tuberculosis[1]. These compounds had predicted activity as serine?threonine protein kinase inhibitors, however spontaneous drug resistant Mycolicibacterium smegmatis mc 2 155 (formerly Mycobacterium smegmatis) revealed only the mycobacterial mechanism of resistance to imidazo[1,2-b][1,2,4,5]tetrazines: mutations in MSMEG_1380 gene lead to overexpression of the mmpS5-mmpL5 operon in M. smegmatis, thus providing resistance to imidazo[1,2-b][1,2,4,5]tetrazines via enhanced efflux [2]. Here we report the RNA sequencing data of M. smegmatis mc 2  155 culture treated with one of the imidazo[1,2-b][1,2,4,5]tetrazines for 1.5 h and the untreated culture as a control. The mapped reads showed that a total of 1386 genes are differentially expressed in this experiment. A further analysis of these data can shed light of the mechanism of action of imidazo[1,2-b][1,2,4,5]tetrazines. The data generated by RNA-seq (raw reads) have been deposited to NCBI sequence read archive (SRA) and have been assigned a BioProject accession number PRJNA615922.

SUBMITTER: Vatlin AA 

PROVIDER: S-EPMC7298395 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Transcriptomic dataset of <i>Mycolicibacterium smegmatis</i> exposed to an imidazo[1,2-<i>b</i>][1,2,4,5]tetrazine.

Vatlin Aleksey A AA   Klimina Ksenia M KM   Frolova Svetlana G SG   Danilenko Valery N VN   Maslov Dmitry A DA  

Data in brief 20200602


Deciphering the mechanism of action of novel anti-tuberculosis compounds is a key step in the drug development process. We have previously described a number of imidazo[1,2-<i>b</i>][1,2,4,5]tetrazines with a promising activity on <i>Mycobacterium tuberculosis</i>[1]. These compounds had predicted activity as serine‑threonine protein kinase inhibitors, however spontaneous drug resistant <i>Mycolicibacterium smegmatis mc</i> <sup><i>2</i></sup> <i>155</i> (formerly <i>Mycobacterium smegmatis</i>)  ...[more]

Similar Datasets

| S-EPMC6473147 | biostudies-literature
| S-EPMC8371482 | biostudies-literature
| S-EPMC7157563 | biostudies-literature
2022-12-24 | GSE221406 | GEO
| S-EPMC9604228 | biostudies-literature
| S-EPMC8306143 | biostudies-literature
| S-EPMC10433963 | biostudies-literature
| PRJNA675073 | ENA
| PRJNA383139 | ENA
| PRJNA382447 | ENA